Seeking AlphaWed, 24 Jun 2026 10:04:09 GMTFate Therapeutics: FT819 Progress Keeps My Bull Case AliveFATE-3.31%
Zacks Investment ResearchWed, 13 May 2026 14:40:37 GMTFate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue EstimatesFATE-3.31%